A comparison of ventilator-associated pneumonia rates determined by different scoring systems in four intensive care units in the North West of England

Anaesthesia
F A WallaceB A McGrath

Abstract

Ventilator-associated pneumonia is a common healthcare-associated infection with significant mortality, morbidity and healthcare cost, and rates have been proposed as a potential quality indicator. We examined ventilator-associated pneumonia rates as determined by different diagnostic scoring systems across four adult intensive care units in the North West of England. We also collected clinical opinions as to whether patients had ventilator-associated pneumonia, and whether patients were receiving antibiotics as treatment. Pooled ventilator-associated pneumonia rates were 36.3, 22.2, 15.2 and 1.1 per 1000 ventilator-bed days depending on the scoring system used. There was significant within-unit heterogeneity for ventilator-associated pneumonia rates calculated by the various scoring systems (all p < 0.001). Clinical opinion and antibiotic use did not correlate well with the scoring systems (k = 0.23 and k = 0.17, respectively). We therefore question whether the ventilator-associated pneumonia rate as measured by existing tools is either useful or desirable as a quality indicator.

References

Apr 6, 2002·American Journal of Respiratory and Critical Care Medicine·Jean Chastre, Jean-Yves Fagon
Dec 12, 2002·Chest·Jordi RelloUNKNOWN VAP Outcomes Scientific Advisory Group
Sep 5, 2003·Intensive Care Medicine·Philippe EggimannDidier Pittet
Oct 21, 2003·Intensive Care Medicine·Carolina A M SchurinkMarc J M Bonten
Jan 8, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Stéphane HugonnetDidier Pittet
Jan 11, 2005·The American Journal of Medicine·Cameron DezfulianSanjay Saint
Feb 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN Infectious Diseases Society of America
Oct 11, 2005·Critical Care Medicine·Nasia SafdarSanjay Saint
Dec 7, 2007·Annals of Internal Medicine·Michael Klompas, Richard Platt
Oct 25, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Alicia I HidronUNKNOWN Participating National Healthcare Safety Network Facilities
Jul 14, 2009·Journal of Critical Care·Eva TejerinaJosé María Rodríguez-Barbero
Mar 20, 2010·Intensive Care Medicine·Jordi RelloUNKNOWN VAP Care Bundle Contributors
Oct 13, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lila BouadmaJean-Christophe Lucet
Mar 30, 2011·PloS One·Michael KlompasUNKNOWN CDC Prevention Epicenters Program
Apr 5, 2011·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Sean M BerenholtzPeter J Pronovost
Aug 17, 2011·Current Opinion in Critical Care·Jean-François TimsitSylvie Chevret
Aug 20, 2011·American Journal of Respiratory and Critical Care Medicine·Maarten BekaertUNKNOWN Outcomerea Study Group
Dec 3, 2011·American Journal of Infection Control·Margaret A DudeckJonathan R Edwards
Jan 18, 2012·Current Opinion in Infectious Diseases·Michael Klompas
Feb 9, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Marin H KollefFrank R Ernst
Nov 20, 2012·American Journal of Infection Control·Noyal Mariya JosephSubhash Chandra Parija
Nov 21, 2012·Critical Care Medicine·Michael Klompas
Oct 10, 2015·Scottish Medical Journal·Neil Houston, Paul Bowie

❮ Previous
Next ❯

Citations

Jul 12, 2016·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Gökhan MetanSerhat Ünal
Oct 18, 2016·Anaesthesia·B A McGrathS Thomas
Sep 1, 2018·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Aline WolfensbergerHugo Sax
Feb 25, 2020·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Ping ZhangFurong Wang
Jun 4, 2020·Journal of the Intensive Care Society·Robert HartSarah Ramsay

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
Breena R TairaMarc J Shapiro
The Pediatric Infectious Disease Journal
Nicola Principi, Susanna Esposito
© 2021 Meta ULC. All rights reserved